| Literature DB >> 27085068 |
D A Ornelles1, L R Gooding2, M L Dickherber3, M Policard3, C Garnett-Benson4.
Abstract
Mucosal lymphocytes support latent infections of species C adenoviruses. Because infected lymphocytes resist re-infection with adenovirus, we sought to identify changes in cellular gene expression that could inhibit the infectious process. The expression of over 30,000 genes was evaluated by microarray in persistently infected B-and T-lymphocytic cells. BBS9, BNIP3, BTG3, CXADR, SLFN11 and SPARCL1 were the only genes differentially expressed between mock and infected B cells. Most of these genes are associated with oncogenesis or cancer progression. Histone deacetylase and DNA methyltransferase inhibitors released the repression of some of these genes. Cellular and viral gene expression was compared among leukemic cell lines following adenovirus infection. Childhood leukemic B-cell lines resist adenovirus infection and also show reduced expression of CXADR and SPARCL. Thus adenovirus induces limited changes to infected B-cell lines that are similar to changes observed in childhood leukemic cell lines.Entities:
Keywords: Adenovirus; Gene-expression; Human adenovirus; Human lymphocytes; Latent; Leukemia; Lymphocytes; Oncogenesis; Species C; Viral persistence
Mesh:
Year: 2016 PMID: 27085068 PMCID: PMC4946252 DOI: 10.1016/j.virol.2016.03.015
Source DB: PubMed Journal: Virology ISSN: 0042-6822 Impact factor: 3.616
Primer-probe sequences.
| Gene symbol | Gene name | Oligo | Sequence |
|---|---|---|---|
| BTG3 | BTG family, member 3 | Primer 1 | GCTTTCAGGACATCAGGATCA |
| BTG3 | BTG family, member 3 | Primer 2 | CAGTTGAGAGGTTTGCTGAGA |
| BTG3 | BTG family, member 3 | Probe | TCTGAAATTTATTGACACGAATACATCTGTAGGCC |
| CXADR | coxsackie virus and adenovirus receptor | Primer 1 | GGCTTTTTCAATCATCTCTTCAGG |
| CXADR | coxsackie virus and adenovirus receptor | Primer 2 | TGCTGTGCTTCGTGCTC |
| CXADR | coxsackie virus and adenovirus receptor | Probe | AACTTCTGGCGAAATCCACTACTCCG |
| SPARCL1 | SPARC-like 1 (hevin) | primer1 | GATCCTTCAATCCCAGCTCTT |
| SPARCL1 | SPARC-like 1 (hevin) | primer2 | CAGCAGTATCCACAGAAGACG |
| SPARCL1 | SPARC-like 1 (hevin) | probe | AGCCATGAACAGTCAGCAGAACAGG |
| BNIP3 | BCL2/adenovirus E1B 19 kDa interacting protein 3 | primer1 | TGTTGGTATCTTGTGGTGTCTG |
| BNIP3 | BCL2/adenovirus E1B 19 kDa interacting protein 3 | primer2 | GCATGAGTCTGGACGGAGTA |
| BNIP3 | BCL2/adenovirus E1B 19 kDa interacting protein 3 | probe | CTCACTGTGACAGCCCACCTCG |
| SLFN11 | schlafen family member 11 | primer1 | TGTTCCAGGCCTTTCTTGG |
| SLFN11 | schlafen family member 11 | primer2 | GATGACAGACACAGATCCAGAT |
| SLFN11 | schlafen family member 11 | probe | CCTCCCCTTAGCAGACCAGTGT |
| BBS9 | Bardet-Biedl syndrome 9 | primer1 | GCACGTAGACTGATAATTTGGC |
| BBS9 | Bardet-Biedl syndrome 9 | primer2 | ACTGACCTTGTCCCTTCTGT |
| BBS9 | Bardet-Biedl syndrome 9 | probe | ACTCTGTTCTGCAGTGTGACCTTCAC |
| CD44 | CD44 molecule (Indian blood group) | primer1 | TCCAAATCTTCCACCAAACCT |
| CD44 | CD44 molecule (Indian blood group) | primer2 | TCTTCAACCCAATCTCACACC |
| CD44 | CD44 molecule (Indian blood group) | probe | ACGCTTCAGCCTACTGCAAATCCA |
| EIF1 | eukaryotic translation initiation factor 1 | primer1 | GATATAATCCTCAGTGCCAGCA |
| EIF1 | eukaryotic translation initiation factor 1 | primer2 | GTATCGTATGTCCGCTATCCAG |
| EIF1 | eukaryotic translation initiation factor 1 | probe | CTCCACTCTTTCGACCCCTTTGCT |
| GAPDH | glyceraldehyde-3-phosphate dehydrogenase | primer1 | TGTAGTTGAGGTCAATGAAGGG |
| GAPDH | glyceraldehyde-3-phosphate dehydrogenase | primer2 | ACATCGCTCAGACACCATG |
| GAPDH | glyceraldehyde-3-phosphate dehydrogenase | probe | AAGGTCGGAGTCAACGGATTTGGTC |
Fig. 1Relative levels of gene expression in infected and non-infected KE37 and BJAB cells. Gene expression levels were determined after normalization by the four methods indicated in Fig. 1 and described in the Materials and Methods. An empirical Bayes method was used to calculate a moderated t-statistic for differentially expressed genes where the proportion of differentially expressed genes (a priori probability) was assumed to be 0.4% or about 150 genes. Volcano plots (panels A–D and F–I) display the log of the odds ratio for differentially expressed genes in virus-infected cells versus the log2 fold change in gene expression. Green symbols indicate probes with a log2 fold-decrease of at least 1.5. Magenta symbols indicate probes associated with a log2 fold-increase of at least 1.5. Saturated colors highlight probes with an odds ratio greater than one. The top 150 differentially expressed Affymetrix probes from each normalization algorithm are compared in the Venn diagrams in panels E and J. The number of probes found to increase in the virus-infected cells are shown in magenta. The number of probes found to decrease are shown in green. The four probes common for the KE37 cell line represent four genes (BCL2A1, CXXC5, HEIH, TAF1D). The nine probes common for the BJAB cell line represents six genes (BBS9, BNIP3, BTG3, CXADR, SLFN11, and SPARCL1).
Fold-decrease in infected BJAB cells relative to mock-infected cells.
| Gene | Method | ||||
|---|---|---|---|---|---|
| qPCR | SVN | RMA | MAS-5 | GC-RMA | |
| 2.1 | 3.9 | 4.9 | 6.8 | 8.4 | |
| BNIP3 | 2.1 | 9.0 | 28 | 488 | 2810 |
| 11.7 | 5.9 | 6.9 | 5.6 | 17 | |
| 6.4 | 8.2 | 14.5 | 119 | 6470 | |
| 8.7 | 5.6 | 13.7 | 10.4 | 120 | |
| 1030 | 7.2 | 16.2 | 320 | 34 | |
| deviation | 0 | 2.0 | 2.3 | 2.8 | 5.3 |
The method used to determine the relative change in gene expression is indicated.
The relative deviation from values determined by qPCR is the average magnitude of the difference of the log2-transformed values for all six genes.
Fig. 2Confirmation of differentially expressed candidate genes from chronically infected BJAB cells. RNA was isolated from mock-infected and chronically infected KE37 or BJAB cells and analyzed by qPCR after reverse transcription. The relative level of expression for the indicated genes compared to mock-infected cells was determined by the −ΔΔCt method using EIF1 as an endogenous control. The average change in expression determined in three independent infections is plotted on a log scale with error bars representing the SD. Levels in virus-infected cells that were significantly different compared to mock-infected cells were identified with the t-test applied to the ΔΔCt. (*p-value ≤ 0.05; **p-value ≤ 0.005).
Fig. 3Six patterns of coordinately expressed genes are identified by the EPIG algorithm. (A) Relative mRNA levels determined by the SVN algorithm were used to identify coordinately expressed genes. Genes from infected cells (closed symbols) are compared with those of mock-infected cells (open symbols) on a log scale. Horizontal lines indicate the geometric mean for each group of three independent cultures. KE37 T-cells are shown in red, BJAB B-cells in blue. Mean values range from a 1.6-fold increase to a 1.6-fold decrease. (B) The relative changes in all 1008 coordinately expressed genes from each sample are represented by green and magenta for a relative decrease or increase in virus-infected cells, respectively. Darker colors indicate the lack of differential expression.
Fig. 4Epigenetic repression of CXADR, SPARCL1, SLFN11, and BNIP3 in AdV-infected BJAB cells is released through inhibition of DNA methyltransferase. Persistently infected BJAB cells were treated with 300 nM TSA (HDAC Class I & Class II inhibitor), 10 µM 5-AzaC (DNA methyltransferase inhibitor) for 48 h. Relative quantity of gene message was analyzed by RT-qPCR. 4-1BBL is shown as a control gene whose expression exhibits little change in these cell lines and was not significantly modulated following infection of lymphocytic cell lines. Fold-change in gene expression is normalized to a housekeeping gene and compared to untreated cells (expression set to 1). Error bars represent SD. Results show the average of two or three independent experiments. Statistical significance is indicated for values with three independent measurements (*p < 0.05; ns, p > 0.05).
Leukemic B cell lines from children are refractory to adenovirus infection compared to adult B cell lines.
| Cell Line | Translocation | Fusion | CAR | Viral Products | ||||
|---|---|---|---|---|---|---|---|---|
| Early | Late | DNA | ||||||
| B cell (childhood) | ||||||||
| REH | t(12;21)(q13;q22) | − | − | − | − | |||
| UoC-B4 | t(12;21)(q13;q22) | − | − | − | − | |||
| RS4;11 | t(4;11)(q21;q23) | − | + | − | − | |||
| SEM | t(4;11)(q21;q23) | − | + | + | + | |||
| EU-8 | t(4;11)(q21;q23) | − | − | − | − | |||
| KOPN-8 | t(11;19)(q23;p13) | − | + | − | − | |||
| RCH-ACV | t(1;19)(q23;p13) | − | + | − | − | |||
| 697 (EU-3) | t(1;19)(q23;p13) | Yes | + | + | + | |||
| B cell (adult) | ||||||||
| ARH77 | Unknown | None | Yes | + | + | + | ||
| Ramos | Unknown | None | Yes | + | + | + | ||
| RPMI-1788 | Unknown | None | − | − | + | + | ||
| SB | Unknown | None | − | − | + | + | ||
| Raji | t(8;14)(q24;q32) | Yes | + | + | + | |||
| BJAB | t(2;8)(p12;q24) | Yes | + | + | + | |||
Known chromosomal translocation associated with leukemia.
Leukemic fusion product arising from the chromosomal translocation.
Cell lines with at least 5% of cells displaying levels of CAR above background as measured by flow cytometry were considered positive for CAR (yes).
The ability to direct early gene expression was assessed with an EGFP-expressing adenovirus vector. Cell lines that showed at least 25% GFP-positive after infection with the viral vector with in 3 dpi were considered permissive for early gene expression (+).
The ability to direct late gene expression was assessed by infection with a wild-type virus. Cell lines with at least 30% hexon-positive cells measured within 3 dpi by flow cytometry were considered permissive for late gene expression (+).
Cell lines that amplified viral DNA by at least 4-fold over input levels following infection with the wild-type virus were considered to support viral DNA replication (+).
Fig. 5Two of the six genes repressed in AdV-infected cells show significantly reduced expression in childhood leukemic cell lines compared to adult leukemic cell lines. Relative mRNA levels comparing adult and childhood leukemic lines were determined and are plotted as a fold-change (2−ΔΔCt). In some experiments, mRNA for CXADR and SPARCL1 could not be detected in the childhood leukemic cell lines. For these cases, the mRNA level was set to a limiting value determined by a Ct of 40. The t-test was used to determine if the mean level for each gene in the childhood leukemic cell lines (blue) was significantly different the mean level for the adult cell lines (yellow/orange). A p-value of less than 0.05 was considered significant. Because the Ct was assigned a limiting value in certain cases, p-values for CXADR and SPARCL1 must be considered an estimate. The fold-change shown for these values (indicated with a break in the bar) represents an upper limit.
CXADR and SPARCL expression is epigenetically regulated in childhood leukemic cell linesa.
| Gene | Fold-change relative to untreated cells | |||||
|---|---|---|---|---|---|---|
| Treatment | Cell line | |||||
| ARH77 | BJAB | UoC-B4 | RS4;11 | KOPN-8 | ||
| TSA | 1.2 | 1.4 | 24.1 | 1.2 | 3.2 | |
| AzaC | 1.5 | 1.2 | 137.3 | 199 | 183 | |
| TSA | 1.4 | 1.1 | 1.7 | 6.8 | 1.4 | |
| AzaC | 2.3 | 6.9 | 2.6 | 36.3 | 2.8 | |
| TSA | 0.9 | 1.1 | 1 | 1.2 | 0.97 | |
| AzaC | 1.8 | 1.5 | 1.1 | 6.1 | 0.94 | |
Total cellular RNA was isolated from cells that were untreated, treated with TSA or 5-AzaC for 48 h.
Relative levels of mRNA for the indicated gene were measured by RT-qPCR and are expressed relative to the level measured in untreated cells for each cell line.
TSA was used at 50 nM for UoC-B4 cells and 300 nM for all other cell lines. 5-AzaC was used at a 10 uM.